trending Market Intelligence /marketintelligence/en/news-insights/trending/rczotokgft1grnqnot_whq2 content esgSubNav
In This List

Mirati Therapeutics plans common stock offering

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Mirati Therapeutics plans common stock offering

California-based Mirati Therapeutics Inc. plans to offer and sell its common shares in an underwritten public offering.

The clinical-stage oncology company plans to grant the underwriters an option to buy additional shares.

Cowen, Barclays and SunTrust Robinson Humphrey are acting as joint book-running managers in the offering.